Plain-English translation of NCT07146633 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing an app-based version of a therapy called Eye Movement Desensitization and Reprocessing (EMDR), which is designed to help people process traumatic memories. The study is for people who have both post-traumatic stress disorder (PTSD) and a substance use disorder. Researchers want to see if using this treatment app can safely reduce symptoms over four weeks.
Many people struggle with both trauma and substance use at the same time, and traditional EMDR therapy may not be accessible to everyone due to cost or availability. This trial is exploring whether a self-guided app version of this proven therapy could make treatment more available and help people recover.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either start the app-based therapy right away or wait four weeks before beginning. You'll use the treatment app over a four-week period, and the research team will check in with you at week four and again at week eight to see how you're doing. The study lasts eight weeks total, though if you're in the waiting group, your active treatment period is shorter.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Canada
Sponsor
Centre for Addiction and Mental Health
Enrollment target
~24 participants
Started
January 2026
Primary completion
January 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.